MNKD
NASDAQ · Biotechnology
Mannkind Corp
$2.38
+0.09 (+3.93%)
Open$2.35
Previous Close$2.29
Day High$2.38
Day Low$2.33
52W High$6.51
52W Low$2.81
Volume—
Avg Volume11.46M
Market Cap818.01M
P/E Ratio122.15
EPS$0.02
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+1,228.2% upside
Current
$2.38
$2.38
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 348.20M | 229.41M | 248.98M |
| Net Income | 5.86M | 3.48M | -49,454,944 |
| Profit Margin | 1.7% | 1.6% | -19.9% |
| EBITDA | 49.39M | 30.92M | -82,218,351 |
| Free Cash Flow | — | — | -29,596,680 |
| Rev Growth | +51.8% | +51.8% | +22.2% |
| Debt/Equity | 1.64 | 1.64 | 1.00 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |